Seroprevalence of SARS-CoV-2 specific IgG antibodies in District Srinagar, northern India - a cross-sectional study
S. M. S. Khan, M. A. Qurieshi, I. Haq, S. Majid, A. A. Bhat, S. Nabi, N. A. Ganai, N. Zahoor, A. Nisar, I. N. Chowdri, T. B. Qazi, R. Kousar, A. A. Lone, I. Sabah, S. Nabi, , S. Ayoub
The paper estimates SARS-CoV-2 seroprevalence in District Srinagar, finding 3.6% IgG antibodies and suggesting underreporting of infections.
bioRxiv · Sep 4, 2020Immunology